100.33
Lemaitre Vascular Inc stock is traded at $100.33, with a volume of 180.50K.
It is up +4.02% in the last 24 hours and up +24.80% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$96.45
Open:
$96.91
24h Volume:
180.50K
Relative Volume:
1.16
Market Cap:
$2.27B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
54.83
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+4.61%
1M Performance:
+24.80%
6M Performance:
+0.79%
1Y Performance:
+16.43%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LMAT
Lemaitre Vascular Inc
|
100.33 | 2.15B | 213.03M | 41.32M | 33.49M | 1.83 |
![]()
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
![]()
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
Aug-02-24 | Resumed | Lake Street | Buy |
May-31-24 | Resumed | ROTH MKM | Buy |
Apr-26-24 | Upgrade | Stifel | Hold → Buy |
Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-06-23 | Initiated | Oppenheimer | Outperform |
Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Sep-16-21 | Initiated | Jefferies | Buy |
Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
Jul-25-19 | Reiterated | Barrington Research | Outperform |
Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
Jun-08-18 | Resumed | ROTH Capital | Buy |
Apr-26-18 | Downgrade | Stifel | Buy → Hold |
Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
Mar-21-17 | Initiated | First Analysis Sec | Overweight |
Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
Jul-28-16 | Reiterated | Barrington Research | Outperform |
Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Russell Investments Group Ltd. Has $22.17 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Cetera Investment Advisers Acquires 5,769 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Is LeMaitre Vascular Inc. Forming a Bottom PatternJuly 2025 Recap & Long-Term Safe Return Strategies - thegnnews.com
Public Sector Pension Investment Board Buys 13,953 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Ex-Dividend Reminder: CenterPoint Energy, LeMaitre Vascular and Concentra Group Holdings Parent - Nasdaq
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Bridget A. Ross Sells 2,500 Shares - MarketBeat
John A. Roush Sells 6,561 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock - MarketBeat
Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells 939 Shares of Stock - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells $999,197.85 in Stock - MarketBeat
Can Traders Expect Breakout From LeMaitre Vascular Inc. This WeekJuly 2025 Market Mood & Daily Entry Point Trade Alerts - beatles.ru
LeMaitre Vascular Dividend and Recent Developments: Insights Ahead of Ex-Dividend Date Aug 21, 2025 - AInvest
Townsquare Capital LLC Sells 7,622 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Has LeMaitre Vascular Inc. found a price floorInsider Buying & Weekly Market Pulse Alerts - Newser
What data driven models say about LeMaitre Vascular Inc.’s futureJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Using Python tools to backtest LeMaitre Vascular Inc. strategies2025 Key Lessons & Safe Entry Trade Signal Reports - Newser
Is LeMaitre Vascular Inc. stock bottoming outBull Run & Fast Exit/Entry Strategy Plans - Newser
Real time social sentiment graph for LeMaitre Vascular Inc.2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Will LeMaitre Vascular Inc. Sustain Its Chart BreakoutMarket Rally & Weekly Consistent Profit Watchlists - newsyoung.net
Can volume confirm reversal in LeMaitre Vascular Inc.Quarterly Earnings Summary & Real-Time Volume Surge Alerts - Newser
What makes LeMaitre Vascular Inc. stock price move sharplyJuly 2025 Market Mood & Verified Momentum Watchlists - thegnnews.com
LeMaitre Vascular’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Nigeria
LeMaitre Vascular’s SWOT analysis: stock poised for growth amid challenges - Investing.com
Published on: 2025-08-15 03:47:19 - classian.co.kr
PNC Financial Services Group Inc. Has $509,000 Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 100,000 Shares of Stock - MarketBeat
LeMaitre Vascular Executives and Directors Sell Shares - TradingView
Lemaitre Vascular director Roush sells $695k in LMAT stock By Investing.com - Investing.com Nigeria
Lemaitre Vascular director Roush sells $695k in LMAT stock - Investing.com
LeMaitre Vascular director Ross sells $235k in shares By Investing.com - Investing.com Canada
LeMaitre Vascular director Ross sells $235k in shares - Investing.com
Barrington Research Has Positive Outlook of LMAT Q3 Earnings - MarketBeat
Roth Capital Forecasts Higher Earnings for LeMaitre Vascular - MarketBeat
Can LeMaitre Vascular (LMAT) Balance Consistent Dividends With Sustained Earnings Growth? - simplywall.st
How to interpret RSI for LeMaitre Vascular Inc. stockIntraday Movement Recap and Chart Summary - Newser
LMAT Q2 Deep Dive: International Expansion and Product Momentum Drive Upbeat Outlook - ca.finance.yahoo.com
LeMaitre Vascular Inc. Recovery Hinges on Volume Breakout2025 Historical Comparison & Safe Entry Zone Tips - sundaytimes.kr
Can LeMaitre Vascular Inc. outperform in the next rallyUndervalued High Return Candidates - newsyoung.net
Roth Capital Lifts Earnings Estimates for LeMaitre Vascular - MarketBeat
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lemaitre Vascular Inc Stock (LMAT) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Roberts David B | President and Director |
Aug 11 '25 |
Option Exercise |
37.27 |
10,815 |
403,069 |
24,689 |
Roberts David B | President and Director |
Aug 11 '25 |
Sale |
92.39 |
10,815 |
999,173 |
17,976 |
Ross Bridget A | Director |
Aug 08 '25 |
Option Exercise |
37.29 |
2,500 |
93,225 |
5,416 |
Ross Bridget A | Director |
Aug 08 '25 |
Sale |
94.00 |
2,500 |
235,000 |
2,916 |
Roush John A | Director |
Aug 11 '25 |
Option Exercise |
37.29 |
6,561 |
244,660 |
9,477 |
Roush John A | Director |
Aug 08 '25 |
Option Exercise |
37.29 |
939 |
35,015 |
3,855 |
Roush John A | Director |
Aug 11 '25 |
Sale |
92.55 |
6,561 |
607,231 |
2,916 |
Roush John A | Director |
Aug 08 '25 |
Sale |
93.49 |
939 |
87,784 |
2,916 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):